236 related articles for article (PubMed ID: 34008144)
21. Goflikicept and Related IL-1 Inhibitors in the Treatment of Recurrent Pericarditis.
Feldman JM; Frishman WH; Aronow WS
Cardiol Rev; 2024 May; ():. PubMed ID: 38709249
[TBL] [Abstract][Full Text] [Related]
22. Rilonacept use in lupus pericarditis.
Fava A; Cammarata M; Adamo L
Clin Exp Rheumatol; 2024 May; 42(5):1115-1117. PubMed ID: 38526001
[TBL] [Abstract][Full Text] [Related]
23. Current treatment of recurrent pericarditis: safety considerations and future directions.
Imazio M
Expert Opin Drug Saf; 2022 Feb; 21(2):183-190. PubMed ID: 34334059
[TBL] [Abstract][Full Text] [Related]
24. New Developments in the Management of Recurrent Pericarditis.
Imazio M; Mardigyan V; Andreis A; Franchin L; De Biasio M; Collini V
Can J Cardiol; 2023 Aug; 39(8):1103-1110. PubMed ID: 37075863
[TBL] [Abstract][Full Text] [Related]
25. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.
Brucato A; Imazio M; Gattorno M; Lazaros G; Maestroni S; Carraro M; Finetti M; Cumetti D; Carobbio A; Ruperto N; Marcolongo R; Lorini M; Rimini A; Valenti A; Erre GL; Sormani MP; Belli R; Gaita F; Martini A
JAMA; 2016 Nov; 316(18):1906-1912. PubMed ID: 27825009
[TBL] [Abstract][Full Text] [Related]
26. Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020.
Tombetti E; Mulè A; Tamanini S; Matteucci L; Negro E; Brucato A; Carnovale C
Curr Cardiol Rep; 2020 Jun; 22(8):59. PubMed ID: 32562029
[TBL] [Abstract][Full Text] [Related]
27. [Pericarditis].
Marques C; Cacoub P
Rev Prat; 2021 Jan; 71(1):79-83. PubMed ID: 34160952
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
Scardapane A; Brucato A; Chiarelli F; Breda L
Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial.
Klein AL; Lin D; Cremer PC; Nasir S; Luis SA; Abbate A; Ertel A; LeWinter M; Beutler A; Fang F; Paolini JF
Heart; 2020 Nov; 107(6):488-96. PubMed ID: 33229362
[TBL] [Abstract][Full Text] [Related]
30. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
Imazio M; Lazaros G; Gattorno M; LeWinter M; Abbate A; Brucato A; Klein A
Eur Heart J; 2022 Aug; 43(31):2946-2957. PubMed ID: 34528670
[TBL] [Abstract][Full Text] [Related]
31. Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors.
Lo Presti S; Elajami TK; Reyaldeen R; Anthony C; Imazio M; Klein AL
J Am Heart Assoc; 2021 Oct; 10(19):e021685. PubMed ID: 34569270
[TBL] [Abstract][Full Text] [Related]
32. What is rilonacept's role in treating recurrent pericarditis?
Schwier NC
JAAPA; 2022 Nov; 35(11):18-19. PubMed ID: 36282574
[TBL] [Abstract][Full Text] [Related]
33. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
[TBL] [Abstract][Full Text] [Related]
35. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
[TBL] [Abstract][Full Text] [Related]
36. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
[TBL] [Abstract][Full Text] [Related]
37. Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
Wohlford GF; Buckley LF; Vecchié A; Kadariya D; Markley R; Trankle CR; Chiabrando JG; de Chazal HM; Van Tassell B; Abbate A
J Cardiovasc Pharmacol; 2020 Jul; 76(1):50-52. PubMed ID: 32398478
[TBL] [Abstract][Full Text] [Related]
38. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences.
Lotrionte M; Biondi-Zoccai G; Imazio M; Castagno D; Moretti C; Abbate A; Agostoni P; Brucato AL; Di Pasquale P; Raatikka M; Sangiorgi G; Laudito A; Sheiban I; Gaita F
Am Heart J; 2010 Oct; 160(4):662-70. PubMed ID: 20934560
[TBL] [Abstract][Full Text] [Related]
39. Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis.
Imazio M; Andreis A; Piroli F; Lazaros G; Gattorno M; Lewinter M; Klein AL; Brucato A
Heart; 2021 Jul; 107(15):1240-1245. PubMed ID: 33737453
[TBL] [Abstract][Full Text] [Related]
40. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis.
Andreis A; Imazio M; Giustetto C; Brucato A; Adler Y; De Ferrari GM
Heart; 2020 Oct; 106(20):1561-1565. PubMed ID: 32868281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
